FACTORS RELATED TO THE RESULTS OF ENDOVASCULAR INTERVENTION IN THE TREATMENT OF CHRONIC FEMORAL-POLITEAL ARTERY OCCLUSION TASC C AND D IN THE ELDERLY
Main Article Content
Abstract
Objectives: Evaluating the results of endovascular intervention in the treatment of stenosis/occlusion of the femoral-popliteal artery TASC C, D in elderly patients. Methods: Retrospective- case series deciptive study conducted at Cardiovascular and Thoracic Surgery Department, Thong Nhat Hospital. Ho Chi Minh city. Results: From June 2020 to June 2024, there were 83 cases of stenosis/occlusion of the femoral-popliteal artery TASC C, D; Average age 77.4 ± 7.4 years (65-99); 64 males (77.1%) and 19 females (22.9%); vascular lesions TASC C (43.4%), TASC D (56.6%), mean ABI was 0.5 ± 0.2. Technical success 97.5% (balloon angioplasty 3.6%, balloon angioplasty + stent 93.9%), failure 2.4%. Average intervention time 118 ± 17.3 minutes (90.5 – 135); Complications: hematoma in 9 cases (10.8%), 1 case of balloon rupture during dilation. The average post-intervention ABI was 0.8 ± 0.2. The results of endovascular intervention depend on factors: the older age and the more severe level of vascular damage, the lower success rate and the longer intervention duration (p<0.05). Conclusion: Endovascular intervention in treatment of stenosis/occlusion of stenosis/occlusion of the femoral-popliteal artery TASC C, D, especially for the elderly has a high technical success rate, the older age and the more severe level of vascular damage, the lower success rate and the longer intervention duration.
Article Details
Keywords
Endovascular intervention, stenosis/ occlusion of the femoral-popliteal artery TASC C, D
References
2. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision-making. J Vasc Surg. 2010;51(5 Suppl):52S-68S.
3. Baker C, Wong D. The Wong-Baker FACES pain rating scale. Pediatric Nursing. 1987;14(1):9-17.
4. Giannopoulos S, Armstrong EJ. Risk factors and outcomes of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2020;59(4):512-518. doi:10.1016/j.ejvs.2019.12.024.
5. Rammos C, Sianis A, Werner C, et al. Coronary artery disease in peripheral arterial disease. J Vasc Surg. 2024;70(3):1234-1242. doi:10.1016/j.jvs.2024.01.045.
6. Zeller T, Rastan A, Macharzina R, Pilger E. Endovascular therapy of chronic femoral artery occlusions. J Cardiovasc Surg. 2011;52(3):357-366.
7. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision-making. J Vasc Surg. 2010;51(5 Suppl):52S-68S.
8. Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Eur J Vasc Endovasc Surg. 2015;49(4):519-529. doi:10.1016/j.ejvs.2015.01.019.
9. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879-1888. doi:10.1056/ NEJMoa051303.
10. Liu Z, Chen X, Wang Y, et al. Endovascular therapy for TASC II C and D femoropopliteal occlusive disease: outcomes and predictors of patency. J Vasc Surg. 2023;78(4):987-994. doi:10.1016/j.jvs.2023.03.015.